tradingkey.logo

Health Canada Has Authorized CSL's Andembry® As Once-Monthly Treatment For Hereditary Angioedema

ReutersAug 8, 2025 12:06 PM

- CSL Ltd CSL.AX:

  • HEALTH CANADA HAS AUTHORIZED CSL'S ANDEMBRY® (GARADACIMAB) AS ONCE-MONTHLY TREATMENT FOR HEREDITARY ANGIOEDEMA (HAE)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI